Category: venture capital
Why AI startups’ economics will likely improve over time
Hello and welcome back to our regular morning look at private companies, public markets and the gray space in between. If you can recall February, we dug into the question of AI startup gross margins. Venture shop a16z had published an interesting blog on the subject, arguing that it may…
Read More
New guidance on SBA loans means most startups are still excluded from $349 billion stimulus
Under new guidance issued by the Small Business Administration it seems non-profits and faith-based groups can apply for the Paycheck Protection Program loans designed to keep small business afloat during the COVID-19 epidemic, but most venture-backed companies are still not covered. Late Friday night, the Treasury Department updated its rules…
Read More
Insight closes $9.5B fund to help support portfolio companies through the pandemic crunch
We’re now several weeks into what is has become a very big dip for the global economy due to the coronavirus pandemic, but amidst that, we are seeing are some notable pockets of investment activity emerging that will help shape how the future startup landscape will look. Today one of…
Read More
The pendulum will swing away from founder-friendly venture raises
Hello and welcome back to our regular morning look at private companies, public markets and the gray space in between. This morning brought fresh economic bad news for the US economy, with over 700,000 jobs lost in the latest report, despite the window of time measured not including some of…
Read More
Longtime VC Neil Sequeira: funding founders without in-person meetings is ‘quite difficult’
Neil Sequeira was a managing director with General Catalyst for more than 13 years before co-founding early-stage firm Defy several years ago with another veteran of the industry, Trae Vassallo, who’d spent the dozen years prior with Kleiner Perkins. We caught up with Sequeira yesterday afternoon and discussed whether he’s…
Read More
ARCH Venture Partners raises $1.46 billion across two funds for biotech investing
Against a backdrop where the life-or-death consequences of biotechnology innovation are becoming increasingly apparent as the world races to develop vaccines and therapies to treat COVID-19, life sciences investor ARCH Venture Partners has raised $1.46 billion in funding to finance new tech development. The two funds, ARCH Venture Fund X…
Read More